Uriage Thermal Water for a Red Face (2012 AAD San Diego)

Written by on March 31, 2012 in Red Face of Rosacea, research with 0 Comments

I have to admit that I had never heard of Uriage Thermal Water before reading this poster abstract. Best I can tell, Uriage Thermal Water is a mineral water sourced from the French Alps.  It “possesses an exceptionally high content of mineral salts and trace elements in comparison with thermal waters used in dermatology (i.e. 11,000 mg/l). These mineral salts and trace elements have an essential biological role that gives it recognized properties with regard to the skin.” [see UTW]

The positive results from the study were based on the participants own clinical subject signs ie. how they rated their own stinging, discomfort, tightening and heat sensations. Uriage Thermal Water was able to show a statistically significant reduction in stinging sensations.

We are not told about any results for any reduction in the objective measures: erythema, edema and scaling. Even though the poster title mentions Facial Redness, the quoted results don’t specifically mention any reduction in erythema.

I’d say these results are on the weak side but could be interesting for those who want to try something like UTW.

Poster reference number 5011

Facial redness: Diagnosis and adjuvant topical use of thermal water in a series of 232 cases

American Academy of Dermatology 70th Annual Meeting, March 16–20, 2012, San Diego, California. Poster Abstracts, Supplement to JAAD, April 2012, Volume 66, Number 4.

Marius Anton Ionescu, MD, PhD, Dermatology Polyclinic, Saint-Louis Hospital, Paris, France; Luc Lefeuvre, PhD, Laboratoires Dermatologiques d’Uriage, Courbevoie, France; Michel Bohbot, PhD, Laboratoires Dermatologiques d‘Uriage, Courbevoie, France

Background: Uriage thermal water (UTW) is prescribed as topical adjuvant in post laser treatments or in chronic skin conditions as rosacea, atopic dermatitis.

Purpose: To assess the dermatologic entities included usually in the term of ‘‘facial red skin’’ and the benefit of UTW in the management of these conditions.

Methods: This open multicenter study (51 dermatologists) included adult patients consulting for a facial inflammatory, irritant or allergic skin condition (‘‘red skin’’).

UTW was prescribed in monotherapy or in association with dermocosmetic care or medical treatment. UTWwas applied for 4 weeks, with 2 examinations (baseline and week 4).

Clinical subjective criteria (stinging, discomfort, ‘‘tightening,’’ and ‘‘heat’’ sensations) and objective (erythema, edema, and scaling) were followed (scores from 0 [absent] to 4 [severe]).

Results: We included 232 patients, 81.6% female, 18.3% male, mean age 44. Fitzpatrick phototypes were: II, 50.2%; III, 35.9%; I and IV, 13.9%. The diagnosis and indications for the use of UTW were: rosacea 36.2%, postlaser 14.3%, seborrheic dermatitis 11.4%, post-dermosurgery procedure (peeling, fillers, electrocoagulation, and phototherapy) 10.5%, contact dermatitis 15.7%, atopic dermatitis 4.8%, postdermatologic treatment (AHA or isotretinoin) 3.3%, other 3.8%. UTW was prescribed in monotherapy in 52% of cases and in association with other treatments in 48%.

Clinical subjective signs were significantly improved after UTW use in monotherapy at week 4 compared to baseline (P<.001).

Self-assessment showed an improvement of ‘‘stinging’’ sensations in 80% of patients and a ‘‘soothing sensation’’ in 87%.

Skin tolerance was good to excellent in 96.6% of cases.

Conclusion: In this series of 232 patients with a diagnosis of ‘‘facial red skin’’ (postlaser, rosacea, or seborrheic dermatitis), UTW decreased significantly clinical subjective signs (P<.001).

Commercial support: 100% by Laboratoires Dermatologiques d’Uriage.

Related Articles

Read more about: Red Face of Rosacea, research

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed

Leave your comment here


Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.